CIPLA LIMITED

CIPLA.NS
Exchange NSI, Currency in INR
Loading price...

Overview

Previous Close1,373.3
Open1,373
Ask0
Bid0
Day's Range1,347.7 - 1,373
52 Week Range1,165.7 - 1,673
PE Ratio(TTM)32.89
Market Cap₹1,10,353Cr
Volume₹16,80,675
Avg. Volume₹12,48,716
Face Value--
Dividend Yield0.95%

Analyst Consensus

Rating Breakdown (36 analysts)
Strong Buy: 8Buy: 14Hold: 10Sell: 3Strong Sell: 1

Performance

ABSCAGR
YTD1 Month3 Months1 Year2 Years5 Years10 Years
No results to display

Profit/Loss

PARTICULARS
No results to display

Company Profile

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
HQ Location: Mumbai, India
Website: https://www.cipla.com
MD, Global CEO & Director: Mr. Achin Gupta
Employees: 31,369
About Company:
Cipla Limited, together with its subsidiaries, manufactures, develops, sells, and distributes pharmaceutical products in India, the United States, South Africa, and internationally. It offers generic and branded generic medicines, vaccines, active pharmaceutical ingredients, and formulations for various therapeutic areas, such as MI, angina, heart disease, pulmonary disease, kidney disorders, alzheimer's disease, hypertension, arrhythmia, lipid abnormalities and diabetes, obesity, central nervous system, HIV/AIDS, respiratory, asthma, urology, oncology, cardio-metabolism, child health, infectious diseases and critical care, hepatitis, women's health, ophthalmology, and neuro psychiatry. The company is also involved in the consumer healthcare, biosimilars, and specialty businesses. Cipla Limited was incorporated in 1935 and is based in Mumbai, India.